BioCentury
ARTICLE | Company News

Evotec OAI AG, Altana AG deal

October 11, 2004 7:00 AM UTC

EVT will develop a kinase assay for an ALT target. EVT will use its compound library and EVOscreen high throughput screening technology to identify hits for characterization and will optimize the hits...